Anatara Lifesciences Ltd(AU:ANR)
A$0.010.00 (0.00%)
AU:ANR
Anatara Lifesciences Ltd financials statements
A$0.01
At close:0.00 (0.00%)
Want to see AU:ANR full AI Analyst Report?
Anatara Lifesciences Ltd (ANR) Ratios
2 Followers
Anatara Lifesciences Ltd Ratios
AU:ANR's free cash flow for Q4 2026 was AU$-621.29K. For the 2026 fiscal year, AU:ANR's free cash flow was increased by AU$3.00 and operating cash flow was AU$-621.29K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.58 | 1.89 | 5.49 | 2.87 | 4.75 |
| Quick Ratio | 7.58 | 1.89 | 5.49 | 2.87 | 4.75 |
| Cash Ratio | 4.35 | 0.17 | 3.23 | 0.71 | 3.13 |
| Solvency Ratio | -8.57 | -3.19 | -4.72 | -4.04 | -6.22 |
| Operating Cash Flow Ratio | -3.13 | -3.74 | -4.10 | -4.57 | -6.23 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -5.58 | 0.00 | 0.00 | -108.10 |
| Net Current Asset Value | AU$ 711.54K | AU$ 535.88K | AU$ 1.36M | AU$ 921.28K | AU$ 1.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.35 | 0.00 | 0.00 | 0.04 |
| Debt-to-Equity Ratio | 0.00 | 0.76 | 0.00 | 0.00 | 0.05 |
| Debt-to-Capital Ratio | 0.00 | 0.43 | 0.00 | 0.00 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 2.14 | 1.22 | 1.54 | 1.30 |
| Debt Service Coverage Ratio | -304.87 | -2.38 | 0.00 | -842.22 | -104.45 |
| Interest Coverage Ratio | -408.71 | -263.70 | 0.00 | -1386.04 | -910.30 |
| Debt to Market Cap | 0.00 | 0.40 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.38 | -0.16 | 0.67 | 0.11 | 0.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -65.39% | -116.29% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -201.83% | -226.56% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -201.76% | -226.18% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -201.83% | -226.56% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -201.63% | -322.56% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -201.63% | -225.34% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -101.63% | -225.34% | 0.00% | 0.00% |
| Net Income Per EBT | 74.56% | 100.00% | 69.86% | 62.48% | 84.39% |
| EBT Per EBIT | 99.85% | 99.90% | 142.37% | 98.58% | 99.29% |
| Return on Assets (ROA) | -113.75% | -170.21% | -86.83% | -142.54% | -143.26% |
| Return on Equity (ROE) | -131.16% | -364.70% | -106.35% | -218.83% | -185.61% |
| Return on Capital Employed (ROCE) | -176.02% | -361.54% | -106.72% | -355.05% | -214.41% |
| Return on Invested Capital (ROIC) | -131.24% | -103.96% | -74.55% | -221.82% | -175.78% |
| Return on Tangible Assets | -113.75% | -170.21% | -86.83% | -142.54% | -143.26% |
| Earnings Yield | -33.58% | -190.98% | -23.10% | -73.79% | -64.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.94 | 0.96 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 9.51 | 3.02 | 0.31 | 0.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 11541.14 | 811.12 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.84 | 0.39 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 1.02 | 0.56 | 0.00 | 0.00 |
| Cash Conversion Cycle | -401573.87 | 348.75 | 259.46 | -1161.95 | -2257.51 |
| Days of Sales Outstanding | 0.00 | 387.15 | 380.34 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 401573.87 | 38.40 | 120.88 | 1161.95 | 2257.51 |
| Operating Cycle | 0.00 | 387.15 | 380.34 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -757332.33 | -311849.00 | -1308.17 | -340.33 |
| Capital Expenditure Coverage Ratio | 0.00 | -757332.33 | -311849.00 | -1308.17 | -340.33 |
| Operating Cash Flow Coverage Ratio | 0.00 | -5.58 | 0.00 | 0.00 | -33.93 |
| Operating Cash Flow to Sales Ratio | 0.00 | -2.34 | -1.94 | 0.00 | 0.00 |
| Free Cash Flow Yield | -12.21% | -221.99% | -19.85% | -82.42% | -57.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.94 | -0.53 | -4.33 | -1.36 | -1.55 |
| Price-to-Sales (P/S) Ratio | 0.00 | 1.06 | 9.76 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.91 | 1.91 | 4.60 | 2.97 | 2.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.19 | -0.45 | -5.04 | -1.21 | -1.75 |
| Price-to-Operating Cash Flow Ratio | -8.19 | -0.45 | -5.04 | -1.21 | -1.75 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | 0.26 | 0.09 | 0.03 | -0.13 |
| Enterprise Value Multiple | -1.84 | -0.68 | -3.64 | -0.74 | -0.96 |
| Enterprise Value | 2.31M | 1.33M | 5.30M | 2.39M | 2.86M |
| EV to EBITDA | -1.84 | -0.68 | -3.64 | -0.74 | -0.96 |
| EV to Sales | 0.00 | 1.37 | 8.23 | 0.00 | 0.00 |
| EV to Free Cash Flow | -6.80 | -0.59 | -4.25 | -1.06 | -1.28 |
| EV to Operating Cash Flow | -6.80 | -0.59 | -4.25 | -1.06 | -1.28 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.50 | 0.30 | 0.38 | 0.16 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 |
| Tax Burden | 0.75 | 1.00 | 0.70 | 0.62 | 0.84 |
| Interest Burden | 1.00 | 1.00 | 1.42 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.65 | 1.16 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 1.36 | 2.10 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.09 | 0.04 | 0.00 | 0.00 |
| Income Quality | 0.36 | 1.16 | 0.86 | 1.12 | 0.88 |
Currency in AUD
